🔗 Visit the ClinicalTrials.gov page for NCT02170025
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | New and emerging targeted therapies for cystic fibrosis. | BMJ | 2016 | 0.87 |
| 2 | Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives. | Clin Pharmacol | 2016 | 0.77 |